COVID-19 trial

  • Global COVID-19 prevention trial of hydroxychloroquine to resume
    LONDON, June 30 (Reuters): A global trial designed to test whether the anti-malaria drugs hydroxychloroquine and chloroquine can prevent infection with COVID-19 is to restart after being approved by British regulators.    The Medicines and Healthcare Products Regulatory Agency (MHRA) took its decision on what is known as the COPCOV trial after hydroxychloroquine was found in another British trial to have no benefit as a treatment for patients already infected with
  • WHO says looking at interim trial data on HIV drugs to treat COVID-19
    LONDON/GENEVA, June 18 (Reuters): Large multi-country trials of the combination HIV drug lopinavir/ritonavir to treat COVID-19 have recruited thousands of patients and the World Health Organization is now looking at interim data, the UN agency's chief scientist said on Thursday.   Soumya Swaminathan said several thousand patients had been enrolled in the lopinavir/ritonavir arm of the WHO-led Solidarity Trial and in a separate UK-led COVID-19 trial of the drug combi